Dipeptidyl peptidase-4 inhibitors in the treatment of type 2 diabetes: A comparative review

Medicin og biovidenskab

• Dipeptidyl-Peptidase IV Inhibitors 100%
• Hypoglycemic Agents 72%
• Type 2 Diabetes Mellitus 56%
• Dipeptidyl Peptidase 4 34%
• Drug Design 28%
• Weight Gain 23%
• Fasting 20%
• Glucose 15%
• Safety 14%
• Enzymes 13%